The present application describes systems and techniques relating to processing and presenting arrhythmia event information from physiological data, for example, selectively presenting atrial fibrillation events to a medical practitioner.
Over the years, various devices have been used for monitoring hearts in living beings. Additionally, systems have been used to collect and report on heart information obtained from patients.
In general, in one aspect, a heart monitoring system collects heart data from a monitored individual and stores the data at a monitoring center. Collected data can be processed, and graphical representations of the collected information can be presented to medical practitioners to assist in treating heart arrhythmias, such as atrial fibrillation. A system and method can involve operations including identifying arrhythmia events in physiological data obtained for a living being, receiving human assessments of at least a portion of the arrhythmia events, determining a measure of correlation between the human assessments and the identified events, and selectively presenting information regarding the identified events based on the measure of correlation. The operations also can include identifying atrial fibrillation events in physiological data obtained for a living being, obtaining heart rate data for the living being, and presenting information regarding the heart rate data and duration of the atrial fibrillation events together with a common time scale to pictographically represent heart rate trend with atrial fibrillation burden during a defined time period.
One or more of the following advantages can be realized. The heart monitor can loop every twenty-four hours and can automatically transmit heart data at least every twenty-four hours. The system can automatically generate a daily graphical summary of atrial fibrillation (AF) burden for review by a medical practitioner, which can be presented effectively anywhere using one or more communication networks. The AF burden graph can be used for asymptomatic AF detection, drug therapy (rate, rhythm, anti-coagulants), pre/post ablation monitoring, and CHF (congestive heart failure) decompensation. The system can provide an overall sensitivity of 96%, a positive predictivity of over 99%, and artifact rejection of over 90%. In one implementation, the graph only displays events where AF detection is validated by a technician finding AF in over 50% of the automatically identified events.
The details of one or more embodiments are set forth in the accompanying drawings and the description below. Other features and advantages will become apparent from the description, the drawings, and the claims.
Monitor processing device 102 can transmit physiological data (including data related to arrhythmia events) through a communication network 103, which can be a local area network (LAN), a landline telephone network, a wireless network, a satellite communication network, or other suitable network to facilitate two-way communication with monitoring center 104. Advantageously, monitoring center 104 can be located in the same location (e.g., in the same room or building) as monitoring system 109 or at some remote location.
The monitoring center 104 can include a monitoring (or display) station 105 and a processing system 106. In one implementation, a cardiovascular technician (CVT) can use the monitoring station 105 to evaluate physiological data received from monitoring system 109, identifying and reporting, among other things, arrhythmia events (such as atrial fibrillation events). The CVT reports these assessments of the physiological data to the processing system 106, which also receives information related to the arrhythmia events identified by monitoring system 109. As will be explained further below, processing system 106 analyzes this arrhythmia event data (both the human-assessed data from the CVT and the data reported by monitoring system 109) and determines whether to generate a graph (or other similar presentation) related to these events. In certain circumstances, the processing system will send a report related to both arrhythmia and heart rate data to, for example, a physician or other health care provider 108 via transmission path 107—which may be part of the network 103.
At 304, the processing system 106 analyzes both the first and second group of data, determining a measure of correlation between these groups. This process can involve, for example, determining whether a correlation measure exceeds and/or equals a predetermined correlation parameter or whether a correlation measure is less than and/or equals that parameter. If, based on the correlation analysis, the information related to the arrhythmia events is determined to be valid, then the system generates a report relating to both heart rate trend and the arrhythmia events at 305, such as the graph shown in
To illustrate, in one implementation, every ten minutes, the monitoring system 109 transmits a “flag” if it has detected an atrial fibrillation (AF) event in the last ten minutes. In this implementation, the processing system 106 only generates a graph (or graphs) related to heart rate trend and atrial fibrillation burden such as the graph shown in
The term “atrial fibrillation burden” (or more generally, “arrhythmia event burden”) refers generally to the overall amount of time that a patient is in atrial fibrillation (or arrhythmia) over a specified time period, taking into account the number and duration of episodes. Advantageously, employing pictographic presentations, such as those of
Like
At 601, the CVT analyzes this data and reports whether arrhythmia events have occurred, thereby generating a second group of data. The processing system then determines (at 602), based on comparing time stamps associated with each group of data, at least one measure of correlation between the first group of data and the second group of data. To illustrate, if enough of the human-assessed events reported at 601 match the events reported at 503, then the system determines that the data is valid, that is, that there is a high positive predictivity for the identification of arrhythmia events. If such a determination is made, the data associated with each flag reported at 503 is pictographically presented in a form such as
The disclosed system and all of the functional operations described and illustrated in this specification can be implemented in digital electronic circuitry, or in computer hardware, firmware, software, or in combinations of the forgoing. Apparatus can be implemented in a software product (e.g., a computer program product) tangibly embodied in a machine-readable storage device for execution by a programmable processor, and processing operations can be performed by a programmable processor executing a program of instructions to perform functions by operating on input data and generating output. Further, the system can be implemented advantageously in one or more software programs that are executable on a programmable system. This programmable system can include the following: 1) at least one programmable processor coupled to receive data and instructions from, and to transmit data and instructions to, a data storage system; 2) at least one input device; and 3) at least one output device. Moreover, each software program can be implemented in a high-level procedural or object-oriented programming language, or in assembly or machine language if desired; and in any case, the language can be a compiled or an interpreted language.
Also, suitable processors include, by way of example, both general and special purpose microprocessors. Generally, a processor will receive instructions and data from a read-only memory, a random access memory, and/or a machine-readable signal (e.g., a digital signal received through a network connection). Generally, a computer will include one or more mass storage devices for storing data files. Such devices can include magnetic disks, such as internal hard disks and removable disks, magneto-optical disks, and optical disks. Storage devices suitable for tangibly embodying software program instructions and data include all forms of non-volatile memory, including, by way of example, the following: 1) semiconductor memory devices, such as EPROM (electrically programmable read-only memory); EEPROM (electrically erasable programmable read-only memory) and flash memory devices; 2) magnetic disks such as internal hard disks and removable disks; 3) magneto-optical disks; and 4) CD-ROM disks. Any of the foregoing can be supplemented by, or incorporated in, ASICs (application-specific integrated circuits).
To provide for interaction with a user (such as the CVT), the system can be implemented on a computer system having a display device such as a monitor or LCD (liquid crystal display) screen for displaying information to the user and a keyboard and a pointing device such as a mouse or a trackball by which the user can provide input to the computer system. The computer system can be programmed to provide a graphical user interface through which computer programs interact with users.
Finally, while the foregoing system has been described in terms of particular implementations, other embodiments are within the scope of the following claims. For example, the disclosed operations can be performed in a different order and still achieve desirable results. Moreover, the system need not employ 10-minute intervals; many different time intervals are possible (as is no interval at all), including 1 minute, 30 second, and 30-minute intervals. Indeed, because time intervals are not required, the graphs of
This application is a continuation of the U.S. patent application Ser. No. 13/046,673, filed Mar. 11, 2011, which is a continuation of U.S. patent application Ser. No. 11/739,037, filed Apr. 23, 2007, which is a continuation application of and claims the benefit of priority from the U.S. Application entitled “System And Method For Processing And Presenting Arrhythmia Information To Facilitate Heart Arrhythmia Identification And Treatment,” filed Jan. 16, 2004, application Ser. No. 10/760,122, and claims priority from U.S. Provisional Application entitled “Presenting Arrhythmia Information to Facilitate Heart Arrhythmia Identification and Treatment,” filed Nov. 26, 2003, Application Ser. No. 60/525,386, the contents of which are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3832994 | Bicher et al. | Sep 1974 | A |
3921624 | Vogelman | Nov 1975 | A |
4173971 | Karz | Nov 1979 | A |
4339800 | Woods | Jul 1982 | A |
4364397 | Citron et al. | Dec 1982 | A |
4531527 | Reinhold, Jr. et al. | Jul 1985 | A |
4622979 | Katchis et al. | Nov 1986 | A |
4625278 | Wong | Nov 1986 | A |
4630204 | Mortara | Dec 1986 | A |
4635646 | Gilles et al. | Jan 1987 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4791933 | Asai et al. | Dec 1988 | A |
4794532 | Leckband et al. | Dec 1988 | A |
4827943 | Bornn et al. | May 1989 | A |
4883064 | Olson et al. | Nov 1989 | A |
4920489 | Hubelbank et al. | Apr 1990 | A |
4938228 | Righter et al. | Jul 1990 | A |
4951681 | Mortara | Aug 1990 | A |
4952928 | Carroll et al. | Aug 1990 | A |
4958641 | Digby et al. | Sep 1990 | A |
4977899 | Digby et al. | Dec 1990 | A |
4989610 | Patton et al. | Feb 1991 | A |
5025795 | Kunig | Jun 1991 | A |
5058597 | Onoda et al. | Oct 1991 | A |
5080105 | Thornton | Jan 1992 | A |
5090418 | Squires et al. | Feb 1992 | A |
5113869 | Nappholz et al. | May 1992 | A |
5181519 | Bible | Jan 1993 | A |
5191891 | Righter | Mar 1993 | A |
5197479 | Hubelbank et al. | Mar 1993 | A |
5206807 | Hatke | Apr 1993 | A |
5216425 | Erhage | Jun 1993 | A |
5217021 | Steinhaus et al. | Jun 1993 | A |
5223844 | Mansell et al. | Jun 1993 | A |
5226431 | Bible et al. | Jul 1993 | A |
5228450 | Sellers | Jul 1993 | A |
5238001 | Gallant et al. | Aug 1993 | A |
5305202 | Gallant et al. | Apr 1994 | A |
5309920 | Gallant et al. | May 1994 | A |
5350404 | Adams | Sep 1994 | A |
5365935 | Righter et al. | Nov 1994 | A |
5398183 | Elliott | Mar 1995 | A |
5416695 | Stutman et al. | May 1995 | A |
5417222 | Dempsey et al. | May 1995 | A |
5421342 | Mortara | Jun 1995 | A |
5452339 | Siu et al. | Sep 1995 | A |
5490515 | Mortara | Feb 1996 | A |
5501229 | Selker et al. | Mar 1996 | A |
5513645 | Jacobson et al. | May 1996 | A |
5522396 | Langer et al. | Jun 1996 | A |
5544661 | Davis et al. | Aug 1996 | A |
5546950 | Schoeckert et al. | Aug 1996 | A |
5549113 | Halleck et al. | Aug 1996 | A |
5568121 | Lamensdorf | Oct 1996 | A |
5568126 | Andersen et al. | Oct 1996 | A |
5576689 | Queen | Nov 1996 | A |
5581369 | Righter et al. | Dec 1996 | A |
5634468 | Platt et al. | Jun 1997 | A |
5676153 | Smith et al. | Oct 1997 | A |
5678562 | Sellers | Oct 1997 | A |
5680102 | Xydis | Oct 1997 | A |
5704351 | Mortara et al. | Jan 1998 | A |
5718233 | Selker et al. | Feb 1998 | A |
5724025 | Tavori | Mar 1998 | A |
5725559 | Alt et al. | Mar 1998 | A |
5730143 | Schwarzberg | Mar 1998 | A |
5748103 | Flach et al. | May 1998 | A |
5752976 | Duffin et al. | May 1998 | A |
5759199 | Snell et al. | Jun 1998 | A |
5772586 | Heinonen et al. | Jun 1998 | A |
5854994 | Canada et al. | Dec 1998 | A |
5868680 | Steiner et al. | Feb 1999 | A |
5931791 | Saltzstein et al. | Aug 1999 | A |
5942986 | Shabot et al. | Aug 1999 | A |
5944659 | Flach et al. | Aug 1999 | A |
5944669 | Kaib | Aug 1999 | A |
5966692 | Langer et al. | Oct 1999 | A |
6016442 | Hsu et al. | Jan 2000 | A |
6064906 | Langberg et al. | May 2000 | A |
6091990 | Hsu et al. | Jul 2000 | A |
6093146 | Filangeri | Jul 2000 | A |
6102856 | Groff et al. | Aug 2000 | A |
6184779 | Chen | Feb 2001 | B1 |
6198394 | Jacobsen et al. | Mar 2001 | B1 |
6223078 | Marcovecchio | Apr 2001 | B1 |
6246907 | Lin et al. | Jun 2001 | B1 |
6253102 | Hsu et al. | Jun 2001 | B1 |
6266554 | Hsu et al. | Jul 2001 | B1 |
6272377 | Sweeney et al. | Aug 2001 | B1 |
6287252 | Lugo | Sep 2001 | B1 |
6301499 | Carlson | Oct 2001 | B1 |
6302844 | Walker et al. | Oct 2001 | B1 |
6366871 | Geva | Apr 2002 | B1 |
6409661 | Murphy | Jun 2002 | B1 |
6411840 | Bardy | Jun 2002 | B1 |
6416471 | Kumar et al. | Jul 2002 | B1 |
6418340 | Conley et al. | Jul 2002 | B1 |
6449504 | Conley et al. | Sep 2002 | B1 |
6470210 | Chen et al. | Oct 2002 | B1 |
6701183 | Baker | Oct 2002 | B2 |
6485429 | Forstner | Nov 2002 | B2 |
6490479 | Bock | Dec 2002 | B2 |
6519490 | Wiesel | Feb 2003 | B1 |
6524239 | Reed et al. | Feb 2003 | B1 |
6564077 | Mortara | May 2003 | B2 |
6569095 | Eggers | May 2003 | B2 |
6583796 | Jamar et al. | Jun 2003 | B2 |
6609023 | Fischell et al. | Aug 2003 | B1 |
7263399 | Carlson | Oct 2003 | B2 |
6648827 | Heikkila et al. | Nov 2003 | B2 |
6665558 | Kalgren et al. | Dec 2003 | B2 |
6668188 | Sun et al. | Dec 2003 | B2 |
6687685 | Sadeghi et al. | Feb 2004 | B1 |
6697655 | Sueppel et al. | Feb 2004 | B2 |
6708057 | Morganroth | Mar 2004 | B2 |
6760620 | Sippens Groenewegen | Jul 2004 | B2 |
6793625 | Cavallaro et al. | Sep 2004 | B2 |
6843801 | Conley et al. | Jan 2005 | B2 |
6871211 | Labounty et al. | Mar 2005 | B2 |
6907284 | Hamilton et al. | Jun 2005 | B2 |
6925324 | Shusterman | Aug 2005 | B2 |
6934578 | Ramseth | Aug 2005 | B2 |
6937887 | Bock | Aug 2005 | B2 |
6968227 | MacAdam et al. | Nov 2005 | B2 |
6978169 | Guerra | Dec 2005 | B1 |
7001334 | Reed et al. | Feb 2006 | B2 |
7092751 | Erkkila | Aug 2006 | B2 |
7187965 | Bischoff et al. | Mar 2007 | B2 |
7223234 | Stupp et al. | May 2007 | B2 |
7311665 | Hawthorne et al. | Dec 2007 | B2 |
7319900 | Kim et al. | Jan 2008 | B2 |
7490085 | Walker et al. | Feb 2009 | B2 |
7532924 | Ternes | May 2009 | B2 |
7542878 | Nanikashvili | Jun 2009 | B2 |
7835910 | Hakkani-Tur et al. | Nov 2010 | B1 |
8043213 | Hatlestad et al. | Oct 2011 | B2 |
8187181 | Osorio et al. | May 2012 | B2 |
20020077561 | Jamar | Jun 2002 | A1 |
20020099303 | Bardy | Jul 2002 | A1 |
20020128804 | Geva | Sep 2002 | A1 |
20020143266 | Bock | Oct 2002 | A1 |
20020147409 | Baker | Oct 2002 | A1 |
20020173727 | Bardy | Nov 2002 | A1 |
20030028442 | Wagstaff et al. | Feb 2003 | A1 |
20030069486 | Sueppel et al. | Apr 2003 | A1 |
20030069487 | Mortara | Apr 2003 | A1 |
20030204146 | Carlson | Oct 2003 | A1 |
20030216654 | Xu | Nov 2003 | A1 |
20040010201 | Korzinov et al. | Jan 2004 | A1 |
20040054294 | Ramseth | Mar 2004 | A1 |
20040059238 | Fischell | Mar 2004 | A1 |
20040073098 | Geva et al. | Apr 2004 | A1 |
20040093239 | Ott et al. | May 2004 | A1 |
20040162497 | Bennett | Aug 2004 | A1 |
20050119833 | Nanikashvili | Jun 2005 | A1 |
20050203349 | Nanikashvili | Sep 2005 | A1 |
20070100213 | Dossas et al. | May 2007 | A1 |
Number | Date | Country |
---|---|---|
360412 | Mar 1990 | EP |
0505627 | Sep 1992 | EP |
1227752 | Aug 2002 | EP |
1754440 | Feb 2007 | EP |
6399840 | May 1998 | JP |
10243930 | Sep 1998 | JP |
2000195910 | Jul 2000 | JP |
2003000559 | Jan 2003 | JP |
2003130815 | May 2003 | JP |
4300523 | Jul 2009 | JP |
WO-9318710 | Sep 1993 | WO |
WO-2001076461 | Oct 2001 | WO |
WO-2002024276 | Mar 2002 | WO |
Entry |
---|
Japanese Patent Application No. 2006-541106, Dispatch date May 18, 2010, Decision of Refusal, 9 pages, including translation. |
Massimo Santini et al., “Atrial Fibrillation: The Role of Atrial Defibrillation”, Journal of Interventional Cardiac Electrophysiology 9, 229-233, 2003. |
Med Monitoring Systems, Inc. (Holter, Spiro, OMS, EGG, EKG, APB), http:f/www.medmonitoringsystems.com/ <http://www.medmonitoringsystems.com/> holtertestanalysis2.html [Retrieved Nov. 13, 2003]. |
Canadian Intellectual Property Office, Application No. 2544926, filed Apr. 28, 2006, in Office Action dated Jun. 22, 2011, 2 pages. |
Australian Patent Office, Application No. 2004305423, in office action dated Nov. 23, 2007, 2 pages. |
Savi Wireless 0 Mobile Cardiac Telemetry Brochure, published by at least May 2009, 12 pages, Medicomp, Melbourne, Florida. |
Crawford, ACC/AHA Guidelines for Ambulatory Electrocardiography, ACC/AHA Practice Guidelines (“ACC Guidelines”), Journal of the American College of Cardiology, vol. 34, No. 3, Sep. 1999, pp. 912-948. |
Bock, E., “Atrial Fibrillation Detection for Patient Monitoring,” (2002) (Bock II). |
CardioNet, Inc., et al., v. Mednet Healthcare Technologies, Inc., et al., Civil Action No. 12-cv-2517, Memorandum, Claim Construction Opinion, Nov. 15, 2013. |
CardioNet, Inc., et al., v. Mednet Healthcare Technologies, Inc., et al., Civil Action No. 12-cv-2517 (JS), Plaintiff CardioNet, Inc.'s Opening Claim Construction Memorandum, Jan. 9, 2013. |
CardioNet, Inc. v. Mednet Healthcare Technologies, Inc., et al., Civil Action No. 12-cv-2517 (JS), Videotaped Deposition of Lev Korzinov, Ph.D., New York, New York, Apr. 11, 2013. |
CardioNet, LLC, et al., v. The ScottCare Corporation, et al., Civil Action No. 12-cv-2516 (PBT), Expert Report of Dr. Bryan Bergeron Regarding the Invalidity of U.S. Pat. Nos. 7,212,850; 7,907,996; 6,569,095; 7,587,237; and 7,941,207, Oct. 31, 2014. |
CardioNet, Inc., et al., v. The ScottCare Corporation, et al., Civil Action No. 1:12-cv-2516, Memorandum, Claim Construction Opinion, Oct. 8, 2014. |
CardioNet, Inc., v. The ScottCare Corporation, et al., Civil Action No. 12-cv-2516 (PBT), Plaintiff CardioNet, Inc.'s Opening Claim Construction Memorandum, Mar. 13, 2013. |
CardioNet, LLC, et al., v. The ScottCare Corporation, et al., Civil Action No. 2:12-cv-02516 (PBT), Videotaped Deposition of Lev Korzinov, Ph.D., New York, New York, Aug. 26, 2014. |
CardioNet Mobile Outpatient Cardiac Telemetry, Physician Inservice Manual, Document No. 100327, Revision A, Jul. 2002. |
Infobionic, Inc., v. Braemar Manufacturing, LLC, Before the Patent Trial and Appeal Board, Declaration of Robert T. Stone, Ph.D., U.S. Appl. No. 7,212,850, Aug. 6, 2015. |
Infobionic, Inc., v. Braemar Manufacturing, LLC, Before the Patent Trial and Appeal Board, Declaration of Robert T. Stone, Ph.D., U.S. Appl. No. 7,907,996, Aug. 6, 2015. |
Infobionic, Inc., v. Braemar Manufacturing, LLC, Before the Patent Trial and Appeal Board, Petition for Inter Partes Review of U.S. Appl. No. 7,212,850, Aug. 10, 2015. |
Infobionic, Inc., v. Braemar Manufacturing, LLC, Before the Patent Trial and Appeal Board, Petition for Inter Partes Review of U.S. Appl. No. 7,907,996, Aug. 10, 2015. |
Park, S. et al., “Cardiac Surveillance at Home,” EP Lab Digest, Nov. 2002. |
Tateno et al., “Automatic detection of atrial fibrillation using the coefficient of variation and density histograms of RR and ΔRR intervals,” Medical & Biological Engineering & Computing 2001, vol. 39, pp. 664-671. |
Cuesta, Biosignal Laboratory: A Software: Tool for Biomedical Signal Processing and. Analysis, Proceedings of the 25th Annual International Conference of the IEEE EMBS, pp. 3544-3547, Sep. 17, 2003. |
Jane, Evaluation of an Automatic Threshold Based Detector of Waveform Limits in Holter ECG with the QT Database, Computers in Cardiology 1997, pp. 295-298, Jul. 10, 1997. |
Zong, Automated ECG Rhythm Analysis Using Fuzzy Reasoning, Computers in Cardiology 1998, pp. 69-72, Sep. 13, 1988. |
Petition for Inter Partes Review of U.S. Pat. No. 7,212,850. |
Petition for Inter Partes Review of U.S. Pat. No. 7,907,996. |
CardioNet, LLC and Braemark Manufacturing, LLC v. Infobionic, Inc., Civil Action No. 1:15-cv-11803-IT, Joint Claim Construction and Prehearing Statement, Oct. 31, 2016. |
Coumel, Clinical Approach to Paroxysmal Atrial Fibrillation, Clin. Cardiol. vol. 13, at 209-212. |
Cuesta, Biosignal Laboratory: A Software: Tool for Biomedical Signal Processing and Analysis, Proceedings of the 25th Annual International Conference of the IEEE EMBS, pp. 3544-3547. |
Falk Ch. 15, Pharmacologic Control of Ventricular Rate in Atrial Fibrillation, in Atrial Fibrillation: Mechanisms and Management, 2d Ed., at 299, 307-311. |
Falk Ch. 24, Clinical Management of Atrial Fibrillation: An Overview, in Atrial Fibrillation: Mechanisms and Management, 2d Ed., at 491, 493. |
Hnatkova, Analysis of the Cardiac Rhythm Preceding Episodes of Paroxysmal Atrial Fibrillation, Am. Heart J., vol. 135, No. 6, Pt. 1, at 1012. |
Kosara, Visualization Methods for Data Analysis and Planning in Medical Applications, Int'l J. of Med. Informatics, 68 (2002), 141-153, at Abstract, 141, 145, 145-146. |
Otsuka, Ambulatory ECG-Respiration Monitoring System, Abstract, Proceedings of the 10th Int'l Congress of Biometeorology, at 130. |
Powsner, Graphical Summary of Patient Status, Lancet, vol. 344, at 386. |
Tufte, The Visual Display of Quantitative Information, 2d Ed., at 30. |
Mar. 10, 2008, CA2544926; Office Action From CA Intellectual Property Office. |
Biomedical Computer Laboratory, Institute for Biomedical Computing, Washington University, “Progress Report No. 21,” Jul. 1, 1984-Jun. 30, 1985, 164 pages. |
Canadian Intellectual Property Office, Application No. 2,544,926, dated Mar. 10, 2008, 3 pages. |
European Patent Office, Application No. 04702945.9, filed Jan. 16, 2004, in Supplementary Partial European Search Report, dated Nov. 11, 2010, 4 pages. |
Japanese Patent Application No. 2006-541106, Dispatch Date Nov. 4, 2009, Notification of Reason(s) for Refusal, with translation, 7 pages. |
Getzow, Scot M., Authorized Officer, International Searching Authority, Application No. PCT/US04/01107, filed Jan. 16, 2005. |
Jan Galuszka et al., “Assessment of Spectral Analysis of Heart Rate Variability in Patients With History of Atrial Fibrillation by Means of Age-Dependent Parameters”, Biomed. Papers 146(2), 81-85 (2002). |
Japanese Patent Office, dated Nov. 4, 2009, Office Action for Application No. JP2006-5411006. |
Jun. 20, 2009, JPO Office Action for patent application No. 2006-541106. |
Number | Date | Country | |
---|---|---|---|
20150190067 A1 | Jul 2015 | US |
Number | Date | Country | |
---|---|---|---|
60525386 | Nov 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13046673 | Mar 2011 | US |
Child | 14593237 | US | |
Parent | 11739037 | Apr 2007 | US |
Child | 13046673 | US | |
Parent | 10760122 | Jan 2004 | US |
Child | 11739037 | US |